Abstract

One major drawback of AMSTAR is that it relies heavily on reporting quality rather than on methodological quality. This can be found in several items. Furthermore, it should be acknowledged that there are now new methods and procedures that did not exist when AMSTAR was developed. For example, the note to item 1 should now refer to the International Prospective Register of Ongoing Systematic Reviews (PROSPERO). Furthermore, item 3 should consider the definition of hand-searching, as the process of reviewing conference proceedings using the search function (e.g. in Microsoft Word or in a PDF file) does not meet the definition set out by the Cochrane Collaboration. Moreover, methods for assessing the quality of the body of evidence have evolved since AMSTAR was developed and should be incorporated into a revised AMSTAR tool. Potential solutions are presented for each AMSTAR item with the aim of allowing a more thorough assessment of SRs. As the AMSTAR tool is currently undergoing further development, our paper hopes to add to preceding discussions and papers regarding this tool and stimulate further discussion.

Keywords

Systematic reviewQuality (philosophy)Computer scienceSet (abstract data type)MedicineMEDLINEManagement scienceData scienceEpistemology

Affiliated Institutions

Related Publications

Publication Info

Year
2016
Type
article
Volume
16
Issue
1
Pages
111-111
Citations
71
Access
Closed

External Links

Social Impact

Social media, news, blog, policy document mentions

Citation Metrics

71
OpenAlex

Cite This

Uta Wegewitz, Beate Weikert, Alba Fishta et al. (2016). Resuming the discussion of AMSTAR: What can (should) be made better?. BMC Medical Research Methodology , 16 (1) , 111-111. https://doi.org/10.1186/s12874-016-0183-6

Identifiers

DOI
10.1186/s12874-016-0183-6